Antibody Therapeutics invites proposals that focus on cell engagers and cell therapies, which advance the understanding, design, and application of these approaches to shape the future of …

Monoclonal antibodies can be acquired in the immune system via passive immunity or active immunity. The advantage of active monoclonal antibody therapy is the fact that the immune system will …

Nov 16, 2021 · Monoclonal antibodies are clones of just one antibody, and they bind to one antigen only. Polyclonal antibodies come from several different types of immune cells and will bind to more than …

May 13, 2024 · In this Review, Paul et al. provide an overview of therapeutic antibodies as an important modality in cancer therapy today. They summarize the different approaches used by antibodies to …

Sep 6, 2022 · Antibody therapies have become an important class of therapeutics in recent years as they have exhibited outstanding efficacy and safety in the treatment of several major diseases …

3 days ago · Yee explores how combination regimens involving bispecific antibodies, CAR T therapies, and small molecules may enhance depth and duration of response over the next 5 years.

4 days ago · FDA immunotherapy approvals in 2025 reflect a major shift in cancer care, expanding immune-based treatments into earlier disease settings, perioperative strategies, and next-generation …

3 days ago · The therapy, an antibody-drug conjugate, targets a protein expressed on the surface of T-cell cancers to deliver a cancer cell-killing drug. The work, published Dec. 22 in Nature Cancer, …

Bispecific antibody therapies harness the immune system to target cancer cells, offering hope when traditional treatments fall short.

Feb 5, 2025 · Monoclonal antibodies have shaped medicine. Biointron reviews their evolution, therapeutic applications, and the future of antibody-based therapies.